Zimmer Biomet Holdings (NYSE:ZBH) witnessed a selling pressure and the shares last traded with a loss of -0.41 points or -0.35% at $116.3. Investors jumped in to buy the shares on weakness. The net money flow till latest update was calculated at $13.46 million with an inflow of $37.49 million in upticks and an outflow of $24.03 million in downticks. Using the data, the up/down ratio is found to be 1.56. The share price has recorded -2.46% on a weekly basis.A block trade of $11.65 million in uptick and $0 million in downtick was also observed, resulting in an up/down ratio of 0. The net money flow of the block trade stood at a $11.65, signaling heavy buying.
Zimmer Biomet Holdings, Inc. has lost 2.31% in the last five trading days and dropped 1.97% in the last 4 weeks. Zimmer Biomet Holdings, Inc. is up 11.71% in the last 3-month period. Year-to-Date the stock performance stands at 13.8%.
Currently the company Insiders own 1.22% of Zimmer Biomet Holdings shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -43.64% . Institutional Investors own 90.52% of Zimmer Biomet Holdings shares. During last six month period, the net percent change held by insiders has seen a change of -43.64%. . On the companys insider trading activities, The Securities and Exchange Commission has divulged that Collins Tony W., officer (VP, Controller and CAO) of Zimmer Biomet Holdings, Inc., had unloaded 3,611 shares at an average price of $116.43 in a transaction dated on June 14, 2016. The total value of the transaction was worth $420,429.
Zimmer Biomet Holdings (NYSE:ZBH) witnessed a decline in the market cap on Friday as its shares dropped 0.2% or 0.23 points. After the session commenced at $116.67, the stock reached the higher end at $116.88 while it hit a low of $115.45. With the volume soaring to 2,234,644 shares, the last trade was called at $116.48. The company has a 52-week high of $123.43. The company has a market cap of $23,207 million and there are 199,238,890 shares in outstanding. The 52-week low of the share price is $88.27.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.